Literature DB >> 22346553

Invasive fungal infections in Canada from 1992 to 1994.

L Nicolle1, C Rotstein, A Bourgault, G St-Germain, G Garber.   

Abstract

PURPOSE: To describe the frequency, characteristics and impact of invasive fungal infection in Canada.
METHODS: Nominal case reporting with standardized data collection from selected sites across Canada. Cases were found primarily through laboratory review with supplementation by record review and clinical surveillance at some sites.
RESULTS: The frequency of invasive fungal infection varied from 3.54 to 6.64/100,000 population per year. Candida species were responsible for 66% of all reports; 80% of candidal infections were bloodstream isolates. Crytococcus neoformans, Aspergillus species and Histoplasma capsulatum each accounted for 5% to 10% of cases, and all other organisms less than 5% each. Human immunodeficiency virus infection was an important comorbidity for cryptococcus and histoplasma infections, and was associated with increased mortality for only histoplasma infections. Geographical variation of histoplasma, blastomyces and coccidioidomyces infection was confirmed. Case fatality was high for all invasive fungal infections, except coccidioidomycosis, blastomycosis and sporotrichosis.
CONCLUSIONS: Candida species infections are the major pathogens in invasive fungal infections in Canada; all other species occur relatively infrequently. The potential for therapeutic intervention to limit mortality requires further assessment.

Entities:  

Keywords:  Blastomycosis; Canada; Candida; Cryptococcosis; Fungal infections; Histoplasmosis

Year:  1998        PMID: 22346553      PMCID: PMC3250875          DOI: 10.1155/1998/473219

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  12 in total

Review 1.  Lipid formulations of amphotericin B: recent progress and future directions.

Authors:  J W Hiemenz; T J Walsh
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

2.  Orthopaedic manifestations of blastomycosis.

Authors:  P B MacDonald; G B Black; R MacKenzie
Journal:  J Bone Joint Surg Am       Date:  1990-07       Impact factor: 5.284

Review 3.  Therapeutic outcome in invasive aspergillosis.

Authors:  D W Denning
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

4.  Blastomycosis in Quebec (1981-90): Report of 23 cases and review of published cases from Quebec.

Authors:  G St-Germain; G Murray; R Duperval
Journal:  Can J Infect Dis       Date:  1993-03

Review 5.  Sporotrichosis of the hand: an urban experience.

Authors:  M M Carr; J C Fielding; G Sibbald; A Freiberg
Journal:  J Hand Surg Am       Date:  1995-01       Impact factor: 2.230

6.  Disseminated histoplasmosis in a nonendemic area.

Authors:  G D Taylor; E A Fanning; J P Ferguson; L D Jewell; A S Sekhon
Journal:  CMAJ       Date:  1985-10-15       Impact factor: 8.262

7.  A comparative study of the pulmonary mycoses of Canada and the United States.

Authors:  L Ajello
Journal:  Public Health Rep       Date:  1969-10       Impact factor: 2.792

Review 8.  Review of human and animal cases of coccidioidomycosis diagnosed in Canada.

Authors:  A S Sekhon; J Isaac-Renton; J M Dixon; L Stein; H V Sims
Journal:  Mycopathologia       Date:  1991-01       Impact factor: 2.574

Review 9.  Disseminated histoplasmosis in patients infected with human immunodeficiency virus.

Authors:  G A Sarosi; P C Johnson
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

10.  Current status of cryptococcosis in Canada.

Authors:  A S Sekhon; S N Bannerjee; B M Mielke; H Idikio; G Wood; J M Dixon
Journal:  Mycoses       Date:  1990-02       Impact factor: 4.377

View more
  12 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Cavitating lung nodule and lytic spinal lesions in an adolescent male.

Authors:  Jennifer M Graham; Saleh Al-Azri; Pierre Schmit; Tim Mailman
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

3.  The Prospective Antifungal Therapy Alliance(®) registry: A two-centre Canadian experience.

Authors:  Shariq Haider; Coleman Rotstein; David Horn; Michel Laverdiere; Nkechi Azie
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

4.  Cutaneous blastomycosis in New Brunswick: case report.

Authors:  J J Ross; D N Keeling
Journal:  CMAJ       Date:  2000-11-14       Impact factor: 8.262

5.  In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.

Authors:  D J Hoban; G G Zhanel; J A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  Serious fungal infections in Canada.

Authors:  S F Dufresne; D C Cole; D W Denning; D C Sheppard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-04       Impact factor: 3.267

7.  An economic evaluation of voriconazole versus amphotericin B for the treatment of invasive aspergillosis in Canada.

Authors:  Coleman Rotstein; Michel Laverdière; Anne Marciniak; Farzad Ali
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

8.  Identification and Evaluation of Novel Drug Targets against the Human Fungal Pathogen Aspergillus fumigatus with Elaboration on the Possible Role of RNA-Binding Protein.

Authors:  Saeid Malekzadeh; Soroush Sardari; Parisa Azerang; Dorsa Khorasanizadeh; Solmaz Agha Amiri; Mohammad Azizi; Nazanin Mohajerani; Vahid Khalaj
Journal:  Iran Biomed J       Date:  2016-12-21

Review 9.  Endemic human blastomycosis in Quebec, Canada, 1988-2011.

Authors:  I V Litvinov; G St-Germain; R Pelletier; M Paradis; D C Sheppard
Journal:  Epidemiol Infect       Date:  2012-08-29       Impact factor: 4.434

Review 10.  Re-drawing the Maps for Endemic Mycoses.

Authors:  Nida Ashraf; Ryan C Kubat; Victoria Poplin; Antoine A Adenis; David W Denning; Laura Wright; Orion McCotter; Ilan S Schwartz; Brendan R Jackson; Tom Chiller; Nathan C Bahr
Journal:  Mycopathologia       Date:  2020-02-10       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.